查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1663542

灌注放射学市场，按检测类型、按方式、按最终用途、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Perfusion Radiology Market, By Assay Type, By Modality, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年灌注放射学市场规模价值为 28.142 亿美元，2025 年至 2032 年期间的复合年增长率为 4.50%。

灌注放射学市场-市场动态

心血管和神经系统疾病增加

由于生活方式改变和不良的饮食习惯导致心血管和神经系统疾病增多，灌注放射学市场正在成长。根据中风统计小组委员会和美国心臟协会统计委员会发布的统计数据，每年有 795,000 人心臟病发作。 2017年，这些数据被公布。因此，政府资助的计划、医疗机构和其他组织必须立即制定策略，提高对有助于监测进展和治疗疾病的技术发展知识。透过使用精确的影像方法测量器官血流量，灌注放射学可以帮助医生发现异常、追踪疾病进程并评估治疗效果。人们对精确​​和非侵入性诊断技术的需求日益增长，以治疗复杂的神经和心血管问题，从而推动了灌注放射学的采用，从而推动了创新和市场扩张。

灌注放射学市场 - 关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 4.50%

根据检测类型细分，心血管影像预计将在 2024 年占据最大市场份额

根据最终用途细分，医院将成为 2024 年的主要细分市场

从地区来看，北美是 2024 年最大的收入来源

灌注放射学市场-細項分析：

全球灌注放射学市场根据检测类型、方式、最终用途和地区进行细分。

根据检测类型，市场分为心血管成像、脑部影像和通气成像。 2024 年，市场将由心血管影像类别主导，因为心血管疾病 (CVD) 在世界各地变得越来越普遍。由于电脑断层扫描 (CT) 和磁振造影 (MRI) 等影像技术的发展，灌注放射学在识别和治疗心臟问题方面变得更加准确和有效。此外，医疗成本的上涨以及早期诊断和治疗意识的增强也推动了对心血管影像技术的需求。由于人工智慧（AI）的加入进一步提高了诊断精度，成像系统已成为临床实践中必不可少的一部分。

根据方式，市场分为磁振造影 (MRI)、核子医学和电脑断层扫描 (CT)。 2024 年，电脑断层扫描 (CT) 类别因其广泛的可用性、出色的诊断精度以及提供全面横断面影像的能力而占据主导地位。它们对于治疗中风和评估脑血流至关重要，低剂量 CT 等发展正在促进它们的使用。肿瘤学、神经病学和心血管护理都广泛使用动脉自旋标记 (ASL) 和动态增强 (DCE) 成像等技术。磁振造影（MRI）由于其卓越的软组织对比度、非侵入性能力和无辐射成像而变得越来越受欢迎。

灌注放射学市场-地理洞察

2024 年，北美在全球灌注放射学市场占据主导地位。这种领导地位归功于该地区对医学研究的大力投资、神经和心血管疾病的高发性以及完善的医疗保健基础设施。美国主要推动区域成长，因为其集中了西门子和通用电气等主要市场参与者，并且大力采用先进的成像技术。优惠的报销规定进一步促进了该地区灌注放射学市场的成长。

然而，在整个预测期内，预计欧洲地区的复合年增长率最快。德国、法国和英国凭藉其完善的医疗保健体系、广泛使用尖端技术以及鼓励早期疾病发现的政府计画而处于领先地位。随着欧洲人口老化以及癌症、中风等慢性疾病的发生率上升，对灌注放射学技术的需求越来越大。欧盟促进医学研究和国际医疗保健合作的措施有助于推动灌注放射学市场的扩张。

灌注放射学市场-竞争格局：

在竞争激烈的灌注放射学市场中，多家竞争对手正在争夺更大的份额，例如通用电气公司、西门子医疗股份公司、Sonic Healthcare、InHealth Group、RadNet, Inc. 等。製药公司、软体解决方案提供者和医疗影像设备製造商是重要的产业参与者。为了提高市场地位，这些企业专注于研发、策略联盟、併购和新产品引进。产品组合、技术发展、客户服务、价格政策和品牌声誉是市场竞争力的重要决定因素。为了满足医疗保健提供者的独特要求，改善患者护理并提高整体营运效率，市场参与者努力提供全面的灌注放射学解决方案。例如，2023年5月，Ion Beam Applications SA 在西班牙举行的欧洲心血管成像协会（EACVI）会议期间介绍了一种基于PET心肌灌注成像的不同寻常的组合解决方案AKURACY。 IBA 是 EURONEXT 的成员，在放射性药物生产解决方案和粒子加速器技术开发领域处于领先地位。

目录

第 1 章：灌注放射学市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 灌注放射学市场片段（依检测类型）
    • 灌注放射学市场片段（按方式）
    • 灌注放射学市场片段（依最终用途）
    • 灌注放射学市场片段（按国家/地区）
    • 灌注放射学市场片段（按地区）
  • 竞争洞察

第 3 章：灌注放射学主要市场趋势

  • 灌注放射学市场驱动因素
    • 市场驱动因素的影响分析
  • 灌注放射学市场限制
    • 市场限制的影响分析
  • 灌注放射学市场机会
  • 灌注放射学市场未来趋势

第 4 章：灌注放射学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：灌注放射学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠肺炎疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长领域
    • 最鬆散的部分
    • 边际损失部分

第 6 章：灌注放射学市场格局

  • 灌注放射学市占率分析，2024 年
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：灌注放射学市场 - 依检测类型

  • 概述
    • 按检测类型分類的细分市场份额分析
    • 心血管影像
    • 脑部影像
    • 通气成像

第 8 章：灌注放射学市场 - 按方式

  • 概述
    • 按方式分類的细分市场占有率分析
    • 磁振造影（MRI）
    • 核子医学
    • 电脑断层扫描 (CT)

第 9 章：灌注放射学市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 诊所
    • 诊断实验室
    • 其他的

第 10 章：灌注放射学市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美灌注放射学主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按检测类型）
    • 北美市场规模及预测（按方式）
    • 北美市场规模和预测，按最终用途
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲灌注放射学主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（按检测类型）
    • 欧洲市场规模及预测（依方式）
    • 欧洲市场规模和预测，按最终用途
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区灌注放射学主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太市场规模及预测（依检测类型）
    • 亚太市场规模及预测（依方式）
    • 亚太市场规模及预测（依最终用途划分）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲灌注放射学主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按检测类型）
    • 拉丁美洲市场规模及预测（按方式）
    • 拉丁美洲市场规模及预测（依最终用途划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲灌注放射学主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按检测类型）
    • 中东和非洲市场规模及预测（按方式）
    • 中东和非洲市场规模及预测（按最终用途划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-灌注放射学产业

  • 竞争仪錶板
  • 公司简介
    • GENERAL ELECTRIC COMPANY
    • Siemens Healthineers AG
    • Sonic Healthcare
    • InHealth Group
    • RadNet, Inc.
    • Spectrum Health
    • Alliance HealthCare Services
    • Hologic Inc.
    • Koninklijke Philips NV
    • RamSoft, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4697

REPORT HIGHLIGHT

Perfusion Radiology Market size was valued at US$ 2,814.2 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Perfusion radiology is the study of blood flow patterns in particular bodily parts, organs, or tissues. It entails giving contrast agents, which improve blood vessel visibility and make it easier to see blood flow in real-time. Perfusion radiology allows radiologists to evaluate tissue viability, spot regions of decreased or increased blood flow, and spot anomalies. This diagnostic method is non-invasive and essential for offering important information about how different organs work physiologically. The growing prevalence of chronic diseases, the need for precise diagnostic methods, and improvements in imaging technology are all contributing to the significant rise of the global perfusion radiology market. New software programs and imaging modalities that improve the precision and effectiveness of perfusion radiology procedures are being introduced to the market. Furthermore, the market is expanding due to rising patient and healthcare professional awareness of the advantages of perfusion radiology. Nonetheless, various obstacles, like the high cost of equipment and restricted accessibility in underdeveloped nations, can somewhat impede the perfusion radiology market expansion.

Perfusion Radiology Market- Market Dynamics

Increase in cardiovascular and neurological conditions

The market for perfusion radiology is growing as a result of an increase in cardiovascular and neurological conditions brought on by altered lifestyles and poor eating habits. According to statistics issued by the Stroke Statistics Subcommittee and the American Heart Association Statistics Committee, 795,000 persons have a heart attack annually. In 2017, these figures were made public. Government-funded initiatives, medical facilities, and other organizations must, therefore, immediately devise strategies to raise knowledge of the technological developments that aid in monitoring progress and curing the illness. By using accurate imaging methods to measure organ blood flow, perfusion radiology helps doctors spot anomalies, track the course of diseases, and gauge how well treatments are working. Perfusion radiology adoption is being fueled by the increasing need for precise and non-invasive diagnostic techniques to treat complicated neurological and cardiovascular problems, which is propelling innovation and market expansion.

Perfusion Radiology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on assay type segmentation, cardiovascular imaging was predicted to show maximum market share in the year 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Perfusion Radiology Market- Segmentation Analysis:

The Global Perfusion Radiology Market is segmented on the basis of Assay Type, Modality, End Use, and Region.

On the basis of assay type, the market is segregated into Cardiovascular Imaging, Brain Imaging, and Ventilation Imaging. In 2024, the market was dominated by the cardiovascular imaging category because cardiovascular diseases (CVDs) are becoming more and more common worldwide. Perfusion radiology has become more accurate and effective in identifying and treating cardiac problems due to developments in imaging technologies like computed tomography (CT) and magnetic resonance imaging (MRI). Furthermore, the need for cardiovascular imaging technologies has been fueled by rising healthcare costs as well as increased awareness of early diagnosis and treatment. Imaging systems have become essential in clinical practice due to the further improvement in diagnostic precision brought about by the incorporation of artificial intelligence (AI).

Based on modality, the market is divided into Magnetic Resonance Imaging (MRI), Nuclear Medicine, and Computed Tomography (CT). In 2024, the computed tomography (CT) category held a dominant market share because of its extensive availability, excellent diagnostic precision, and capacity to provide comprehensive cross-sectional images. They are crucial for managing strokes and evaluating cerebral blood flow, and developments such as low-dose CT are encouraging their use. Oncology, neurology, and cardiovascular care all make extensive use of techniques like arterial spin labelling (ASL) and dynamic contrast-enhanced (DCE) imaging. Magnetic resonance imaging (MRI) is becoming more and more popular due to its superior soft-tissue contrast, non-invasive capabilities, and radiation-free imaging.

Perfusion Radiology Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Perfusion Radiology. This leadership is ascribed to the region's strong investments in medical research, high prevalence of neurological and cardiovascular disorders, and well-established healthcare infrastructure. The United States primarily drives regional growth because of its large concentration of major market participants like Siemens and General Electric, as well as its robust adoption of advanced imaging technologies. Favourable reimbursement regulations further aid the growth of the perfusion radiology market in this area.

However, throughout the projected period, the Europe region is anticipated to see the fastest CAGR. Germany, France, and the UK are leading the way because of their sophisticated healthcare systems, widespread use of cutting-edge technologies, and government programs that encourage early disease detection. Perfusion radiology technologies are becoming more and more in demand as Europe's ageing population and the prevalence of chronic illnesses like cancer and stroke rise. The European Union's initiatives to promote medical research and international healthcare partnerships help fuel the perfusion radiology market expansion.

Perfusion Radiology Market- Competitive Landscape:

Several competitors are fighting for a larger share in the very competitive perfusion radiology market, such as GENERAL ELECTRIC COMPANY, Siemens Healthineers AG, Sonic Healthcare, InHealth Group, RadNet, Inc., and others. Pharmaceutical firms, software solution providers, and makers of medical imaging equipment are important industry participants. To improve their market position, these businesses concentrate on R&D, strategic alliances, mergers and acquisitions, and new product introductions. Product portfolio, technology developments, customer service, price policies, and brand reputation are important determinants of market competitiveness. In order to meet the unique requirements of healthcare providers, improve patient care, and increase overall operational efficiency, market participants work hard to deliver comprehensive perfusion radiology solutions. For instance, in May 2023, an unusual combination solution for PET myocardial perfusion-based imaging, AKURACY, was introduced by the Ion Beam Applications S.A. During the meeting of the European Association of Cardiovascular Imaging (EACVI) in Spain, this advanced technology was introduced. IBA, which is a member of EURONEXT, is a leader in the development of radiopharmaceutical production solutions and particle accelerator technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERFUSION RADIOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GENERAL ELECTRIC COMPANY
  • Siemens Healthineers AG
  • Sonic Healthcare
  • InHealth Group
  • RadNet, Inc.
  • Spectrum Health
  • Alliance HealthCare Services
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • RamSoft, Inc.
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY ASSAY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Imaging
  • Brain Imaging
  • Ventilation Imaging

GLOBAL PERFUSION RADIOLOGY MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine
  • Computed Tomography (CT)

GLOBAL PERFUSION RADIOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Perfusion Radiology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Perfusion Radiology Market Snippet by Assay Type
    • 2.1.2. Perfusion Radiology Market Snippet by Modality
    • 2.1.3. Perfusion Radiology Market Snippet by End Use
    • 2.1.4. Perfusion Radiology Market Snippet by Country
    • 2.1.5. Perfusion Radiology Market Snippet by Region
  • 2.2. Competitive Insights

3. Perfusion Radiology Key Market Trends

  • 3.1. Perfusion Radiology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Perfusion Radiology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Perfusion Radiology Market Opportunities
  • 3.4. Perfusion Radiology Market Future Trends

4. Perfusion Radiology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Perfusion Radiology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Perfusion Radiology Market Landscape

  • 6.1. Perfusion Radiology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Perfusion Radiology Market - By Assay Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Assay Type, 2024 & 2032 (%)
    • 7.1.2. Cardiovascular Imaging
    • 7.1.3. Brain Imaging
    • 7.1.4. Ventilation Imaging

8. Perfusion Radiology Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Magnetic Resonance Imaging (MRI)
    • 8.1.3. Nuclear Medicine
    • 8.1.4. Computed Tomography (CT)

9. Perfusion Radiology Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Others

10. Perfusion Radiology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Perfusion Radiology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Perfusion Radiology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Perfusion Radiology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Perfusion Radiology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Perfusion Radiology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Perfusion Radiology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GENERAL ELECTRIC COMPANY
    • 11.2.2. Siemens Healthineers AG
    • 11.2.3. Sonic Healthcare
    • 11.2.4. InHealth Group
    • 11.2.5. RadNet, Inc.
    • 11.2.6. Spectrum Health
    • 11.2.7. Alliance HealthCare Services
    • 11.2.8. Hologic Inc.
    • 11.2.9. Koninklijke Philips N.V.
    • 11.2.10. RamSoft, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us